No Data
No Data
Trending Industry Today: JOINN Leads Gains In CRO Stocks
Daiwa: Maintains wuxi apptec (02359) target price of 50 Hong Kong dollars and a "shareholding" rating
Daiwa believes that if ATU is spun off, the company's focus will return to its core small molecule drug contract development and manufacturing (CDMO) business, potentially reducing the risks faced by wuxi apptec under the "Biological Safety Act" and helping to increase profit margins.
Hong Kong stocks are showing abnormal movements | CRO concept stocks continued to rise in the morning, selling businesses may alleviate doubts, the industry's investment and financing vitality is expected to recover rapidly.
Concept stocks of CRO continue to rise in early trading. As of the time of publication, Joinn Laboratories (06127) rose by 16.04% to HKD 13.02; Pharmaron (03759) rose by 12.9% to HKD 22.15; Tigermed (03347) rose by 5.09% to HKD 55.7; Wuxi Apptec (02359) rose by 2.61% to HKD 68.85; Wuxi Bio (02269) rose by 2.1% to HKD 21.9.
WuXi AppTec Co., Ltd.'s (SHSE:603259) Share Price Boosted 35% But Its Business Prospects Need A Lift Too
Hong Kong Stocks End Week Higher as Tech Counters Rally
Biomedical sector showing strong performance, Pharmaron (03759) rose by 14.97%. Institutions believe there is still room for further increase in sector valuation.
Golden Finance News | The biomedical sector is showing strong performance, with Pharmaron (03759) up 14.97%, Remegen (09995) up 13.59%, Tigermed (03347) up 12.58%, Wuxi Bio (02269) up 11.79%, Wuxi Apptec (02359) up 10.56%, Akeso (09926) up 8.92%. In terms of news, Guoyuan International believes that the main reason for the outperformance of the pharmaceutical sector in this round of large gains is due to the deeper decline in the pharmaceutical sector in the previous period (as of September 23, MSCI China Meheco Group Index has fallen 23% year-to-date), sector.